Straumann Holding AG (Straumann Group) is a Swiss-based medical technology company focused on tooth replacement and orthodontics. Headquartered in Basel and listed on the SIX Swiss Exchange, the company develops, manufactures, and markets dental implants, prosthetic components, biomaterials for bone and soft‑tissue regeneration, and digital dentistry solutions, as well as clear aligner systems. Its products and services are used by dental professionals, laboratories, and clinics worldwide.
The portfolio spans implant and prosthetic systems under brands such as Straumann, Neodent, Anthogyr, and Medentika; clear aligners via ClearCorrect; and CAD/CAM prosthetics and digital workflows including scanning, design, and guided surgery tools. Straumann’s materials and surface technologies include titanium‑zirconium alloys (e.g., Roxolid) and advanced implant surface treatments (e.g., SLActive) designed to support osseointegration and clinical performance.
None yet. When a new project in the record names Straumann Group as owner, partner or investor, it shows here.
The Board also proposes re-electing Ben van Beurden as Chairman and reducing members from eleven to eight.
